Lumos Pharma Inc. buy DomRuinart
Start price
11.01.21
/
50%
€18.00
Target price
11.01.22
€25.00
Performance (%)
-17.22%
End price
25.01.21
€14.90
Summary
This prediction ended on 25.01.21 with a price of €14.90. The prediction for Lumos Pharma Inc. disappointed with a performance of -17.22%. DomRuinart has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Lumos Pharma Inc. | 11.905% | 11.905% | -4.082% | -73.143% |
iShares Core DAX® | 0.000% | -2.064% | 13.111% | 16.685% |
iShares Nasdaq 100 | 0.626% | -2.884% | 37.744% | 43.441% |
iShares Nikkei 225® | 1.568% | -5.892% | 19.592% | 4.617% |
iShares S&P 500 | 0.334% | -2.281% | 27.745% | 41.046% |
According to DomRuinart what are the pros and cons of Lumos Pharma Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by DomRuinart for this prediction
In the thread NewLink Genetics Corp diskutieren
Buy mit Kursziel 25,0
In the thread Trading Lumos Pharma Inc.
Buy beendet